Penn Capital Management Company, LLC Harmony Biosciences Holdings, Inc. Transaction History

Penn Capital Management Company, LLC

  • $983 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$30.8 - $53.92 $6.08 Million - $10.7 Million
197,554 New
197,554 $6.45 Million
Q4 2022

Feb 13, 2023
BUY
$45.4 - $60.91 $1.97 Million - $2.64 Million
43,362 Added 32.7%
175,987 $9.71 Million
Q3 2022

Dec 09, 2022
BUY
$42.06 - $55.45 $5.12 Million - $6.75 Million
121,683 Added 1112.07%
132,625 $5.88 Million
Q3 2022

Nov 14, 2022
BUY
$42.06 - $55.45 $460,220 - $606,733
10,942 New
10,942 $493,000

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Penn Capital Management Company, LLC Portfolio

Follow Penn Capital Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Capital Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email